Adverum Biotechnologies Inc. buy krebskrebs
Start price
26.07.21
/
50%
€1.97
Target price
26.07.22
€3.00
Performance (%)
-23.63%
End price
27.07.22
€1.50
Summary
This prediction ended on 27.07.22 with a price of €1.50. The prediction for Adverum Biotechnologies Inc. disappointed with a performance of -23.63%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Adverum Biotechnologies Inc. | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% |
Comments by krebskrebs for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Adverum Biotechnologies Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten